Equities

Ryvu Therapeutics SA

Ryvu Therapeutics SA

Actions
  • Price (PLN)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of PLN
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments23434588
Total Receivables, Net331712
Total Inventory2.121.761.96
Prepaid expenses--2.351.63
Other current assets, total9.771.480.69
Total current assets278368104
Property, plant & equipment, net788291
Goodwill, net------
Intangibles, net6.344.283.04
Long term investments232029
Note receivable - long term------
Other long term assets170.000.53
Total assets403475229
LIABILITIES
Accounts payable231412
Accrued expenses12124.86
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.541.902.75
Other current liabilities, total321714
Total current liabilities704536
Total long term debt9.221110
Total debt9.761313
Deferred income tax--00.44
Minority interest------
Other liabilities, total657620
Total liabilities14413268
SHAREHOLDERS EQUITY
Common stock9.257.347.34
Additional paid-in capital520279279
Retained earnings (accumulated deficit)66378196
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(335)(321)(321)
Total equity260343161
Total liabilities & shareholders' equity403475229
Total common shares outstanding231818
Treasury shares - common primary issue0.000.020
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.